Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Drug:
dolasetron mesylate
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II/III Randomized Study of Ginger for Chemotherapy-Related Nausea in Patients With Cancer
Phase:
Phase III, Phase II
Type:
Supportive care
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
URCC-U1902
, URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742
2.
Phase III Randomized Study of 3 Regimens For the Prevention of Delayed Nausea After Chemotherapy in Patients With Chemotherapy-Naive Cancer
Phase:
Phase III
Type:
Supportive care
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
URCC-U3901
, NCI-P01-0180, NCT00020657
3.
Phase II Randomized Study of Acupressure and Acustimulation Wrist Bands for the Prevention of Chemotherapy Induced Nausea and Vomiting
Phase:
Phase II
Type:
Supportive care
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
URCC-U3997
, NCI-V99-1528, NCT00003817
4.
Antiemetic Retreatment Protocol with Single-Dose Intravenous MDL 73,147EF in Patients Receiving High-Dose (at Least 80 mg/sqm) Cisplatin (Summary Last Modified 01/92)
Phase:
Phase II
Type:
Supportive care
Status:
Closed
Age:
18 to 90
Sponsor:
Protocol IDs:
MSKCC-90151
, NCI-V91-0013
5.
A Dose Escalation Tolerance Study of Intravenous MDL 73,147EF in Patients Receiving Chemotherapy Regimens Containing High-Dose (at least 100 mg/sqm) Cisplatin (Summary Last Modified 01/92)
Phase:
Phase I
Type:
Supportive care
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
MSKCC-90150
, NCI-V91-0012
6.
Randomized Comparative Study of 1 vs 2 Doses of Oral Dolasetron Mesylate/Dexamethasone as Antiemesis Prophylaxis in Patients Receiving Cisplatin (Summary Last Modified 10/95)
Phase:
No phase specified
Type:
Supportive care
Status:
Completed
Age:
18 and over
Sponsor:
Protocol IDs:
MSKCC-95038
, NCI-V95-0708
7.
Randomized, Double-Blind, Comparative Study of the Antiemetic Effectiveness of Single Dose IV Dolasetron Mesylate vs IV Ondansetron in Patients Receiving First-Line CDDP Chemotherapy (Summary Last Modified 06/93)
Phase:
No phase specified
Type:
Supportive care
Status:
Completed
Age:
18 and over
Sponsor:
Protocol IDs:
MSKCC-92141
, NCI-V92-0193
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute